These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16930355)

  • 1. Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders.
    Angelini C; Federico A; Reichmann H; Lombes A; Chinnery P; Turnbull D
    Eur J Neurol; 2006 Sep; 13(9):923-9. PubMed ID: 16930355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.
    Spiekerkoetter U; Bastin J; Gillingham M; Morris A; Wijburg F; Wilcken B
    J Inherit Metab Dis; 2010 Oct; 33(5):555-61. PubMed ID: 20830526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders].
    Peña Quintana L; Sanjurjo Crespo P
    An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy.
    ; ; van Schaik IN; Bouche P; Illa I; Léger JM; Van den Bergh P; Cornblath DR; Evers EM; Hadden RD; Hughes RA; Koski CL; Nobile-Orazio E; Pollard J; Sommer C; van Doorn PA
    Eur J Neurol; 2006 Aug; 13(8):802-8. PubMed ID: 16879289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke).
    Jennum P; Santamaria J;
    Eur J Neurol; 2007 Nov; 14(11):1189-200. PubMed ID: 17956442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
    Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary carnitine deficiency syndromes.
    Pons R; De Vivo DC
    J Child Neurol; 1995 Nov; 10 Suppl 2():S8-24. PubMed ID: 8576570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
    Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats.
    Wein S; Wolffram S; Schrezenmeir J; Gasperiková D; Klimes I; Seböková E
    Diabetes Metab Res Rev; 2009 Feb; 25(2):185-94. PubMed ID: 19219861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2010 Dec; 15(4):295-301. PubMed ID: 21199100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    ; ; Hadden RD; Nobile-Orazio E; Sommer C; Hahn A; Illa I; Morra E; Pollard J; Hughes RA; Bouche P; Cornblath D; Evers E; Koski CL; Léger JM; Van den Bergh P; van Doorn P; van Schaik IN
    Eur J Neurol; 2006 Aug; 13(8):809-18. PubMed ID: 16879290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    Lauria G; Hsieh ST; Johansson O; Kennedy WR; Leger JM; Mellgren SI; Nolano M; Merkies IS; Polydefkis M; Smith AG; Sommer C; Valls-Solé J; ;
    Eur J Neurol; 2010 Jul; 17(7):903-12, e44-9. PubMed ID: 20642627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay.
    Yamaguchi S; Li H; Purevsuren J; Yamada K; Furui M; Takahashi T; Mushimoto Y; Kobayashi H; Hasegawa Y; Taketani T; Fukao T; Fukuda S
    Mol Genet Metab; 2012 Sep; 107(1-2):87-91. PubMed ID: 22841441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.
    Holloway GP; Bezaire V; Heigenhauser GJ; Tandon NN; Glatz JF; Luiken JJ; Bonen A; Spriet LL
    J Physiol; 2006 Feb; 571(Pt 1):201-10. PubMed ID: 16357012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    ; ; ; ; ; ; ; ; Gersh BJ; Maron BJ; Bonow RO; Dearani JA; Fifer MA; Link MS; Naidu SS; Nishimura RA; Ommen SR; Rakowski H; Seidman CE; Towbin JA; Udelson JE; Yancy CW
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):e153-203. PubMed ID: 22093723
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.